Valuation: Baxter International Inc.

Market Cap 11.79B 10.28B 9.71B 8.81B 16.51B 1,131B 16.58B 116B 44.86B 575B 44.28B 43.3B 1,850B P/E 2026 *
29.2x
P/E 2027 * 19x
Enterprise Value 18.68B 16.29B 15.38B 13.97B 26.17B 1,793B 26.28B 184B 71.11B 912B 70.19B 68.63B 2,933B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.53x
Free-Float
75.39%
Yield 2026 *
0.17%
Yield 2027 * 0.18%
1 day-0.96%
1 week-4.20%
Current month-12.31%
1 month-12.10%
3 months+14.63%
6 months+33.41%
Current year+19.31%
1 week 22.71
Extreme 22.7111
24.22
1 month 22.71
Extreme 22.7111
26.78
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Chief Tech/Sci/R&D Officer 57 2023-12-31
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/26 Tax

President, Front Line Care

-2,098 0.0004%
9/2/26 Tax

Chief Executive Officer

-54,276 0.0105%
9/1/26 Tax

President, CCS

-750 0.0001% -
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-4.20%-3.76%-41.13% 11.79B
+0.37%+0.65%-23.75%+1.59% 178B
-0.69%+1.29%-3.62%+11.27% 118B
-0.20%-3.98%+6.17%+72.47% 58.92B
-0.24%+1.74%-3.94%-31.61% 49.29B
-0.22%-0.37%+7.26%+35.20% 48.17B
+1.61%+7.61%+17.91%-6.24% 33.72B
-1.49%-2.74% - - 27.76B
-1.17%+4.64%+42.09%-8.18% 25.5B
+1.02%+5.99%+7.20%-19.54% 22.1B
Average -0.20%+1.25%+5.06%+1.54% 57.26B
Weighted average by Cap. -0.10%+0.93%-4.28%+8.60%

Financials

2026 *2027 *
Net sales 11.62B 10.13B 9.57B 8.69B 16.27B 1,115B 16.34B 115B 44.22B 567B 43.64B 42.67B 1,824B 11.86B 10.35B 9.77B 8.87B 16.62B 1,138B 16.69B 117B 45.15B 579B 44.57B 43.58B 1,862B
Net income 372M 324M 306M 278M 521M 35.7B 523M 3.67B 1.42B 18.15B 1.4B 1.37B 58.39B 687M 599M 566M 514M 963M 65.97B 967M 6.78B 2.62B 33.54B 2.58B 2.53B 108B
Net Debt 6.9B 6.01B 5.68B 5.16B 9.66B 662B 9.7B 68.02B 26.25B 336B 25.91B 25.33B 1,083B 6.32B 5.51B 5.2B 4.72B 8.85B 606B 8.89B 62.3B 24.04B 308B 23.73B 23.2B 992B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-18 US$22.80 -0.96% 9,968,219
26-09-17 US$23.02 -2.17% 6,615,004
26-09-16 US$23.53 -0.76% 9,453,579
26-09-15 US$23.71 -0.63% 6,145,777
26-09-14 US$23.86 +0.25% 5,741,921
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
22.80USD
Average target price
28.73USD
Spread / Average Target
+26.00%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!